Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
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
TWMgmA13q8eLwB2T
